{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:15:15Z","timestamp":1790118915846,"version":"4.0.1"},"reference-count":92,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Several chronic inflammatory skin disorders have been linked to metabolic syndrome (MetS) and an increased risk for cardiovascular disease. In this review, we will summarize the recent evidence on the association between psoriasis, hidradenitis suppurativa (HS), and atopic dermatitis (AD) and metabolic syndrome with careful attention to this association among the pediatric population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Historically, psoriasis has exhibited the most robust association with MetS in the literature. Recent studies show that the prevalence of MetS appears to be higher among patients with HS and can be associated with MetS even in mild disease. A relationship between AD and MetS is still under debate, but research has shown a clear link between pediatric AD and being overweight or obese.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>There are no current consensus guidelines for metabolic syndrome in the pediatric population, and its clinical implications in children are still unclear. Nevertheless, providers should be aware of the shared underlying inflammatory state and link between several cutaneous disorders and metabolic syndrome. Early diagnosis and proper disease management of these at risk populations has the potential to assist in disease control and mitigate future cardiovascular disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000790","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T13:36:41Z","timestamp":1559828201000},"page":"515-522","source":"Crossref","is-referenced-by-count":13,"title":["Metabolic syndrome and inflammatory skin conditions"],"prefix":"10.1097","volume":"31","author":[{"given":"Chelsea Elizabeth","family":"Steele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231208","article-title":"Syndrome X","volume":"4","author":"Reaven","year":"1992","journal-title":"Blood Press Suppl"},{"key":"R2-20231208","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"R3-20231208","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R4-20231208","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.phrs.2017.01.017","article-title":"An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations","volume":"119","author":"Mameli","year":"2017","journal-title":"Pharmacol Res"},{"key":"R5-20231208","doi-asserted-by":"crossref","first-page":"397","DOI":"10.21037\/tp.2017.10.02","article-title":"Metabolic syndrome in children and adolescents","volume":"6","author":"Al-Hamad","year":"2017","journal-title":"Transl Pediatr"},{"key":"R6-20231208","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(07)60958-1","article-title":"The metabolic syndrome in children and adolescents","volume":"369","author":"Zimmet","year":"2007","journal-title":"Lancet"},{"key":"R7-20231208","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clindermatol.2017.09.014","article-title":"Cutaneous manifestations of obesity and themetabolic syndrome","volume":"36","author":"Uzuncakmak","year":"2018","journal-title":"Clin Dermatol"},{"key":"R8-20231208","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R9-20231208","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.clindermatol.2017.09.012","article-title":"Autoimmune skin diseases and the metabolic syndrome","volume":"36","author":"\u00dcnl\u00fc","year":"2018","journal-title":"Clin Dermatol"},{"key":"R10-20231208","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MAJ.0b013e31823ea214","article-title":"Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes","volume":"343","author":"Leroith","year":"2012","journal-title":"Am J Med Sci"},{"key":"R12-20231208","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1253\/circj.68.975","article-title":"Adiponectin as a biomarker of the metabolic syndrome","volume":"68","author":"Ryo","year":"2004","journal-title":"Circ J"},{"key":"R13-20231208","doi-asserted-by":"crossref","first-page":"H2031","DOI":"10.1152\/ajpheart.01058.2004","article-title":"Adipokines: molecular links between obesity and atheroslcerosis","volume":"288","author":"Lau","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R14-20231208","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3810\/pgm.2012.01.2514","article-title":"Metabolic syndrome: definition and therapeutic implications","volume":"124","author":"Prasad","year":"2012","journal-title":"Postgrad Med"},{"key":"R15-20231208","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clindermatol.2017.09.004","article-title":"Pathophysiology of the metabolic syndrome","volume":"36","author":"McCracken","year":"2018","journal-title":"Clin Dermatol"},{"key":"R16-20231208","doi-asserted-by":"crossref","first-page":"657.e8","DOI":"10.1016\/j.jaad.2017.04.1133","article-title":"Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome","volume":"77","author":"Rodr\u00edguez-Z\u00fa\u00f1iga","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R17-20231208","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jaad.2017.08.034","article-title":"Cardiovascular comorbidities of pediatric psoriasis among hospitalized children in the United States","volume":"77","author":"Kwa","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R18-20231208","doi-asserted-by":"crossref","first-page":"606.e4","DOI":"10.1016\/j.jaad.2014.12.013","article-title":"Association of atopic dermatitis with being overweight and obese: A systematic review and metaanalysis","volume":"72","author":"Zhang","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R19-20231208","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjd.14024","article-title":"Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies","volume":"173","author":"Tzellos","year":"2015","journal-title":"Br J Dermatol"},{"key":"R20-20231208","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ced.13014","article-title":"Psoriasis and metabolic syndrome in children: current data","volume":"42","author":"Pietrzak","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"R21-20231208","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamadermatol.2014.3059","article-title":"Central obesity and high blood pressure in pediatric patients with atopic dermatitis","volume":"151","author":"Silverberg","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R22-20231208","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","article-title":"The metabolic syndrome in children and adolescents - an IDF consensus report","volume":"8","author":"Zimmet","year":"2007","journal-title":"Pediatr Diabetes"},{"key":"R23-20231208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clindermatol.2017.09.001","article-title":"Skin and the metabolic syndrome","volume":"36","author":"Karadag","year":"2018","journal-title":"Clin Dermatol"},{"key":"R24-20231208","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1542\/peds.2006-1699","article-title":"Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study","volume":"120","author":"Morrison","year":"2007","journal-title":"Pediatrics"},{"key":"R25-20231208","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.arcped.2018.12.005","article-title":"Psoriasis and metabolic and cardiovascular comorbidities in children: a systematic review","volume":"26","author":"Badaoui","year":"2019","journal-title":"Arch P\u00e9diatrie"},{"key":"R26-20231208","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaad.2016.07.065","article-title":"Psoriasis and comorbid diseases: implications for management","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R27-20231208","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2133.1978.tb02012.x","article-title":"Psoriasis and occlusive vascular disease","volume":"99","author":"Mcdonald","year":"1978","journal-title":"Br J Dermatol"},{"key":"R28-20231208","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"R29-20231208","first-page":"663","article-title":"Relationship between psoriasis and metabolic syndrome: a systematic review","volume":"151","author":"Singh","year":"2016","journal-title":"G Ital di Dermatologia e Venereol"},{"key":"R30-20231208","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"R31-20231208","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R32-20231208","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jaad.2011.11.935","article-title":"Association between pediatric psoriasis and the metabolic syndrome","volume":"66","author":"Au","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R33-20231208","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1684\/ejd.2014.2291","article-title":"Cardiovascular comorbidities in childhood psoriasis","volume":"24","author":"Torres","year":"2014","journal-title":"Eur J Dermatol"},{"key":"R34-20231208","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jpeds.2011.03.006","article-title":"The association of psoriasis and elevated blood lipids in overweight and obese children","volume":"159","author":"Koebnick","year":"2011","journal-title":"J Pediatr"},{"key":"R35-20231208","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/pde.12218","article-title":"Prevalence of the metabolic syndrome in children with psoriatic disease","volume":"30","author":"Goldminz","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"R36-20231208","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1111\/ajd.12491","article-title":"Prevalence of obesity in paediatric psoriasis and its impact on disease severity and progression","volume":"58","author":"Ergun","year":"2017","journal-title":"Australas J Dermatol"},{"key":"R37-20231208","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOP.0000000000000517","article-title":"Update in the management of pediatric psoriasis","volume":"29","author":"Aileen","year":"2017","journal-title":"Curr Opin Pediatr"},{"key":"R38-20231208","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40257-017-0294-9","article-title":"Pediatric psoriasis","volume":"18","author":"Relvas","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"R39-20231208","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12566","article-title":"Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents","volume":"31","author":"Al Mutairi","year":"2018","journal-title":"Dermatol Ther"},{"key":"R40-20231208","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the metabolic syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin Dermatol"},{"key":"R41-20231208","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/jid.2012.184","article-title":"Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis","volume":"132","author":"Su\u00e1rez-Fari\u00f1as","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R42-20231208","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.intimp.2015.11.005","article-title":"Down-regulation of the Th1, Th17, and Th22 pathways due to anti-TNF-\u03b1 treatment in psoriasis","volume":"29","author":"Luan","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"R43-20231208","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaad.2013.12.036","article-title":"Interleukin 17A: Toward a new understanding of psoriasis pathogenesis","volume":"71","author":"Lynde","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R44-20231208","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00011-017-1065-z","article-title":"Inflammatory skin march\u2019 in atopic dermatitis and psoriasis","volume":"66","author":"Furue","year":"2017","journal-title":"Inflamm Res"},{"key":"R45-20231208","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/abd1806-4841.20175178","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study","volume":"92","author":"Milcic","year":"2017","journal-title":"An Bras Dermatol"},{"key":"R46-20231208","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13098-018-0311-z","article-title":"Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients","volume":"10","author":"Stefanadi","year":"2018","journal-title":"Diabetol Metab Syndr"},{"key":"R47-20231208","doi-asserted-by":"crossref","first-page":"e0181039","DOI":"10.1371\/journal.pone.0181039","article-title":"An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies","volume":"12","author":"Singh","year":"2017","journal-title":"PLoS One"},{"key":"R48-20231208","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clindermatol.2017.09.003","article-title":"Genetics and the metabolic syndrome","volume":"36","author":"Fanning","year":"2018","journal-title":"Clin Dermatol"},{"issue":"(3 Part 1)","key":"R49-20231208","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R50-20231208","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2009.09593.x","article-title":"Epidemiology and comorbidity of psoriasis in children","volume":"162","author":"Augustin","year":"2010","journal-title":"Br J Dermatol"},{"key":"R51-20231208","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2340\/00015555-1607","article-title":"Cardiovascular risk factors in children and adolescents with psoriasis: a case-control study","volume":"94","author":"Jensen","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"R52-20231208","first-page":"282","article-title":"Central obesity in children with psoriasis","author":"Guidolin","year":"2018","journal-title":"Acta Dermatovenerol Croat"},{"key":"R53-20231208","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamadermatol.2013.1078","article-title":"Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study","volume":"149","author":"Paller","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R54-20231208","first-page":"147","article-title":"Update on pediatric psoriasis","volume":"95","author":"Silverberg","year":"2015","journal-title":"Cutis"},{"key":"R55-20231208","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/met.2017.0160","article-title":"Longitudinal associations of metabolic syndrome severity between childhood and young adulthood: the Bogalusa Heart Study","volume":"16","author":"Wang","year":"2018","journal-title":"Metab Syndr Relat Disord"},{"key":"R56-20231208","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ijo.2015.64","article-title":"Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta-analysis","volume":"39","author":"Upala","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"R57-20231208","first-page":"1","article-title":"Management of moderate to severe psoriasis in patients with metabolic comorbidities","volume":"2","author":"Gisondi","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"R58-20231208","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaad.2015.07.002","article-title":"Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study","volume":"73","author":"Landells","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R59-20231208","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa066886","article-title":"Etanercept treatment for children and adolescents with plaque psoriasis","volume":"358","author":"Paller","year":"2008","journal-title":"N Engl J Med"},{"key":"R60-20231208","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/j.1468-3083.2012.04450.x","article-title":"Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry","volume":"27","author":"Gisondi","year":"2013","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"R61-20231208","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"(5 Supplement 1)","key":"R62-20231208","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2015.07.051","article-title":"Hidradenitis suppurativa in the pediatric population","volume":"73","author":"Liy-Wong","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"(5 Suppl 1)","key":"R63-20231208","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaad.2015.07.052","article-title":"Hidradenitis suppurativa: epidemiology and scope of the problem","volume":"73","author":"Jemec","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R64-20231208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.det.2015.08.002","article-title":"Prevalence, risk factors, and comorbidities of hidradenitis suppurativa","volume":"34","author":"Miller","year":"2016","journal-title":"Dermatol Clin"},{"key":"R65-20231208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clindermatol.2017.09.007","article-title":"Hidradenitis suppurativa and the metabolic syndrome","volume":"36","author":"Ergun","year":"2018","journal-title":"Clin Dermatol"},{"key":"R66-20231208","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R67-20231208","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.12688\/f1000research.11337.1","article-title":"Hidradenitis suppurativa: an update on connecting the tracts","volume":"6","author":"Smith","year":"2017","journal-title":"F1000Res"},{"key":"R68-20231208","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.13777","article-title":"Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients","volume":"173","author":"Shalom","year":"2015","journal-title":"Br J Dermatol"},{"key":"R69-20231208","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"key":"R70-20231208","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/jdv.13059","article-title":"Resolution of hidradenitis suppurativa after weight loss by dietary measures, especially on frictional locations","volume":"30","author":"Boer","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R71-20231208","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R72-20231208","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bpobgyn.2014.07.012","article-title":"Hidradenitis suppurativa","volume":"28","author":"Margesson","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R73-20231208","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: a little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R74-20231208","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","article-title":"Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?","volume":"164","author":"Boer","year":"2011","journal-title":"Br J Dermatol"},{"key":"R75-20231208","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1468-3083.2007.02429.x","article-title":"Antitumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study","volume":"22","author":"Gisondi","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R76-20231208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5021\/ad.2016.28.2.147","article-title":"Management of hidradenitis suppurativa in patients with metabolic comorbidities","volume":"28","author":"Lim","year":"2016","journal-title":"Ann Dermatol"},{"key":"R77-20231208","doi-asserted-by":"crossref","first-page":"e12812","DOI":"10.1111\/dth.12812","article-title":"Metabolic syndrome in dermatology: treatment and management for dermatologists","volume":"32","author":"Engin","year":"2019","journal-title":"Dermatol Ther"},{"key":"R78-20231208","doi-asserted-by":"crossref","first-page":"938.e1","DOI":"10.1016\/j.jaci.2015.09.012","article-title":"Atopic disease and cardiovascular risk factors in US children","volume":"137","author":"Silverberg","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R79-20231208","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40257-017-0293-x","article-title":"Association between inflammatory skin disease and cardiovascular and cerebrovascular co-morbidities in us adults: analysis of nationwide inpatient sample data","volume":"18","author":"Kwa","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"R80-20231208","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jid.2016.11.031","article-title":"Association of atopic dermatitis with cardiovascular risk factors and diseases","volume":"137","author":"Standl","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R81-20231208","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMcp042803","article-title":"Clinical practice. Atopic dermatitis","volume":"352","author":"Williams","year":"2005","journal-title":"N Engl J Med"},{"key":"R82-20231208","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/all.12112","article-title":"Characterization of different courses of atopic dermatitis in adolescent and adult patients","volume":"68","author":"Garmhausen","year":"2013","journal-title":"Allergy"},{"key":"R83-20231208","first-page":"359","article-title":"Inside out or outside in: does atopic dermatitis disrupt barrier function or does disruption of barrier function trigger atopic dermatitis?","volume":"96","author":"Silverberg","year":"2015","journal-title":"Cutis"},{"key":"R84-20231208","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/all.13085","article-title":"Prevalence of comorbidity and associated risk factors in adults with atopic dermatitis","volume":"72","author":"Egeberg","year":"2017","journal-title":"Allergy"},{"key":"R85-20231208","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clindermatol.2017.09.010","article-title":"Atopic dermatitis and the metabolic syndrome","volume":"36","author":"Wollina","year":"2018","journal-title":"Clin Dermatol"},{"key":"R86-20231208","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/jid.2014.83","article-title":"TNF-alpha and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents","volume":"134","author":"Danso","year":"2014","journal-title":"J Invest Dermatol"},{"key":"R87-20231208","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jid.2016.08.022","article-title":"Increasing comorbidities suggest that atopic dermatitis is a systemic disorder","volume":"137","author":"Brunner","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R88-20231208","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.anai.2017.09.055","article-title":"Immunologic, microbial, and epithelial interactions in atopic dermatitis","volume":"120","author":"Brunner","year":"2018","journal-title":"Ann Allergy, Asthma Immunol"},{"key":"R89-20231208","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.12685","article-title":"Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies","volume":"70","author":"Silverberg","year":"2015","journal-title":"Allergy"},{"key":"R90-20231208","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000491593","article-title":"Association between atopic dermatitis and the metabolic syndrome: a systematic review","volume":"234","author":"Ali","year":"2018","journal-title":"Dermatology"},{"key":"R91-20231208","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/bjd.16215","article-title":"The association with cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis","volume":"178","author":"Thyssen","year":"2018","journal-title":"Br J Dermatol"},{"key":"R92-20231208","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s40257-018-0383-4","article-title":"Major comorbidities of atopic dermatitis: beyond allergic disorders","volume":"19","author":"Paller","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"R93-20231208","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-1102","article-title":"Recent developments in atopic dermatitis","volume":"142","author":"Yang","year":"2018","journal-title":"Pediatrics"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008480-201908000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T05:03:23Z","timestamp":1702011803000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201908000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000790","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}